The majority of antiparasitic drugs have severe side effects, which is predicted to reduce demand for these drugs. Over example, Nifurtimox, a medicine used to treat Chagas disease, may be ineffective if used for an extended period of time. Other drawbacks, such as drug resistance, unpleasant effects, and the greater cost of antimalarial treatments such as chloroquine, sulphadoxine/pyrimethamine, mefloquine, and others, are likely to stymie the expansion of the antiparasitic drugs industry.
Antiparasitic Drugs are grouped according to their mode of action in order to provide maximum benefit against fungal infections. Antifungal drugs which act on the fungal cells directly are known as drug-based medicines, while those that act on the bacteria are called systemic medications. Systemic medications are required in very low doses and prolonged periods for the complete cure of fungal infections.
Read More@ https://bit.ly/3vnOBOT
